Medical/Pharmaceuticals

European Wellness Collaborates with Heidelberg University in Journal Publications of "Synergistic Anti-Ageing Through Senescent Cells Specific Reprogramming"

HEIDELBERG, Germany, April 28, 2023 /PRNewswire/ -- European Wellness Academy (EWA), an educational arm of European Wellness Biomedical Group (EW Group), has collaborated with Heidelberg University on journal publication. The research project, titled "Synergistic Anti-Ageing Through Senescent Cel...

2023-04-28 11:58 2486

HOYA Vision Care Elevates Children's Protection Against Myopia & Intensive Light With MiYOSMART Sun Lenses

SINGAPORE, April 28, 2023 /PRNewswire/ -- HOYA Vision Care , a leader in optical technology innovation, has launched MiYOSMART Sun spectacle lenses inSingapore, which are designed to be effective and non-invasive protection against myopia for children. The photochrom...

2023-04-28 11:18 2462

Brii Bio Publishes 2022 Environmental, Social and Governance Report

Brii Bio receives an "A" grade in the latest MSCI ESG Rating DURHAM, N.C. and BEIJING, April 28, 2023 /PRNewswire/ -- Brii Biosciences Limited  ("Brii Bio" or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health ...

2023-04-28 09:00 2570

OrthAlign's 50th Patent Affirms Position as A Global Leader in Surgical Navigation

ALISO VIEJO, Calif., April 28, 2023 /PRNewswire/ -- OrthAlign® Inc., a global leader in orthopedic surgical navigation technology, continues to expand its IP portfolio, with its 50th patent being issued. OrthAlign pioneered and continues to enhance surgical navigation solutions proven to enable a...

2023-04-28 04:33 2127

RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine

GERMANTOWN, Md. and GUANGZHOU, China, April 28, 2023 /PRNewswire/ -- RNAimmune, Inc.(the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, today announced that the Company has received a clearance from the Uni...

2023-04-28 00:29 2737

Steakholder Foods® 3D Bio-Prints First Ready-to-Cook Cultivated Grouper Fish

Steakholder Foods 3D bio-printed the world's first cultivated fish fillet: * The Company has reached a significant milestone by successfully customizing bio-inks utilizing grouper cells provided by Umami Meats' to print a cultivated grouper product – a significant step towards the commercializa...

2023-04-27 23:50 4389

Fapon Biotech Announces Chemiluminescence One-Stop Solution Strategy in India at Medical Fair India 2023

NEW DELHI, April 27, 2023 /PRNewswire/ -- Fapon Biotech Inc. (Fapon Biotech, or the Company), a global leading IVD enterprise, has announced its innovative chemiluminescence one-stop solution strategy at the 28th edition of Medical Fair India. Fapon chemiluminescence one-stop solution is designe...

2023-04-27 18:44 1884

Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board

SHANGHAI, April 27, 2023 /PRNewswire/ -- On April 27th Beijing time, Qiming Venture Partners' portfolio company MedSci Healthcare Holdings Limited ("MedSci"), a leading physician digital platform inChina, successfully listed on the main board of Hong Kong Stock Exchange. MedSci (02415.HK)'s issue...

2023-04-27 15:53 2876

Bactiguard Holding AB's report for the first quarter 2023

Continued focus on growth and transformation STOCKHOLM, April 27, 2023 /PRNewswire/ --  First quarter 2023, January-March * Revenues amounted to SEK 61.2 (55.2) million, an increase of 11%. Adjusted for currency effects, revenues decreased by 4%. * Operating loss amounted to SEK 18.7 (16.6) ...

2023-04-27 14:47 1758

BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines

MIAMI and ADELAIDE, Australia, April 27, 2023 /PRNewswire/ -- BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a$5.0m AUD grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to fund wor...

2023-04-27 12:15 2121

MGI and South Australian Genomics Centre Introduce DNBSEQ-T7* to Supercharge Genomics Research in Australia

BRISBANE, Australia, April 27, 2023 /PRNewswire/ -- MGI and  South Australian Genomics Centre (SAGC) are proud to announce their joint efforts to advance genomics research inAustralia by introducing the country's first commercial ultra...

2023-04-27 11:45 2352

Antengene to Release Latest Results from the TORCH-2 Trial of mTORC1/2 Inhibitor ATG-008 in Poster Discussion at 2023 ASCO

SHANGHAI and HONG KONG, April 27, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announ...

2023-04-27 08:30 2640

Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid

MELBOURNE, Australia, April 27, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with the signing of an agreement to acquireVienna-based Dedicaid GmbH (Dedicaid), a spin-off of the Medica...

2023-04-27 06:50 2340

MGI Announces New Customer Experience Center in South Korea with BMS

CHEONAN, South Korea, April 26, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today celebrated the opening of its Customer Experience Center (CEC) inSouth Korea. In partnership with one of the country's leading compan...

2023-04-26 16:00 1861

MGI Secured First Corporate Order of Ultra-high Throughput Sequencer DNBSEQ-T20×2*

SHANGHAI, April 26, 2023 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a global life science tools leader, announced its partnership with Shanghai-based JMDNA Biomedical Technology Co., Ltd. ("JMDNA") for DNBSEQ-T20×2 ("T20"), a sequencer that broke records for its ultra-high throughput and cost-ef...

2023-04-26 15:20 1770

RemeGen Celebrates World Intellectual Property Day 2023

YANTAI, China, April 26, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, is celebrating World Intellectual Property Day 2023 which falls onApril 26, the theme of which mirrors the crit...

2023-04-26 10:00 2322

Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit

MIAMI and PERTH, Australia, April 26, 2023 /PRNewswire/ -- Global private investment firm,Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, establishes LumaCina business unit under Bridgewest Perth Pharma inPerth, Australia. The newly cre...

2023-04-26 06:41 1901

Bioved Pharmaceuticals granted a US Patent for its oral, natural plant-based product, Artovid-20® for the treatment of Covid-19

SAN JOSE, Calif., April 26, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets for Covid-19. The Patent titled "Methods and Compounds for Treating Effects of Covid-19 Disease," grants 2...

2023-04-26 03:00 1644

IF YOU, A CHILD IN YOUR CARE, OR ANOTHER LOVED ONE WERE HARMED BY ENDO OR A RELATED COMPANY, INCLUDING PAR OR AMS, OR THEIR PRODUCTS INCLUDING OPIOIDS, RANITIDINE, OR TRANSVAGINAL MESH, YOUR RIGHTS MAY BE AFFECTED BY DEADLINES IN THE ENDO BANKRUPTCY.

The deadline to file a claim in the bankruptcy is July 7, 2023, at 5:00 p.m. (prevailing Eastern Time). The deadline to object to Endo's sale is July 7, 2023, at 4:00 p.m. (prevailing Eastern Time). NEW YORK, April 25, 2023 /PRNewswire/ -- The following is being issued by Kroll Restructuring Adm...

2023-04-25 22:27 1814

ZEISS Announces U.S. FDA Approval of the CT LUCIA 621P Monofocal IOL, Offering the Unique ZEISS Optic to the U.S. Market

The monofocal IOL enables surgeons to treat a wide range of cataract patients while supporting optimized visual outcomes. JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved theCT LUCI...

2023-04-25 21:00 1719
1 ... 70717273747576 ... 382